Stryker OrthoMap Versatile Hip System

K162937 · Stryker Corporation · OLO · Feb 23, 2017 · Neurology

Device Facts

• Record ID: K162937
• Device Name: Stryker OrthoMap Versatile Hip System
• Applicant: Stryker Corporation
• Product Code: OLO · Neurology
• Decision Date: Feb 23, 2017
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 882.4560
• Device Class: Class 2

Intended Use

The Stryker OrthoMap Versatile Hip system, which is comprised of the OrthoMap Versatile Hip 2.0 Software and a platform of the NAV3i platform family, is intended as a planning and intraoperative guidance system to enable open or percutaneous image guided surgery. The system can be used for intraoperative guidance where a reference to a rigid anatomical structure such as but not limited to the pelvis, or femur, can be identified. The system is indicated for conditions of the hip joint in which the use of image guided surgery may be appropriate. The Stryker OrthoMap Versatile Hip system is indicated for the following surgical procedures: Any form of Total Hip Athroplasty (THA), e.g. open or minimally-invasive Precisely position instruments, implants and bony tissue during orthopedic hip surgery Revisions

Device Story

Stryker OrthoMap Versatile Hip system is a computer-assisted surgical planning and intraoperative guidance system. It utilizes wireless optical tracking technology; infrared light emitted by diodes on navigated surgical instruments is sensed by a camera array on the NAV3i platform. The system computes spatial information to display the real-time location of instruments relative to a computed anatomical model of the patient's pelvis and femur, generated via intra-operative anatomy survey. Used in OR by surgeons; system provides alignment/orientation of instruments, trials, and implants; enables assessment of joint stability, range of motion (ROM), leg length, and leg offset. Output displayed on monitor for surgeon to guide precise positioning of implants and bony tissue. Benefits include improved surgical accuracy and intraoperative assessment of joint mechanics.

Clinical Evidence

Bench testing only. No clinical or animal studies performed. Verification included ASTM F2554-10 accuracy testing, mechanical leg simulation (accuracy ± 2 mm, ± 2°), and simulated total hip arthroplasty procedures using Sawbones to confirm system integration and functionality.

Technological Characteristics

Optical tracking system using infrared active sensing. Components: NAV3i platform (computer, navigation camera, IO-Tablet, monitor), smart instruments, and patient trackers. Accuracy: ± 2 mm, ± 2°. Software: OrthoMap Versatile Hip 2.0. Connectivity: Wireless instrument tracking. Standards: ANSI/AAMI ES60601-1, IEC 60601-1-2, ASTM F2554-10.

Indications for Use

Indicated for patients undergoing hip joint surgery, including Total Hip Arthroplasty (THA) (open or minimally-invasive) and revisions, where image-guided surgery is appropriate and rigid anatomical structures (pelvis/femur) can be identified for reference.

Regulatory Classification

Identification

A stereotaxic instrument is a device consisting of a rigid frame with a calibrated guide mechanism for precisely positioning probes or other devices within a patient's brain, spinal cord, or other part of the nervous system.

Predicate Devices

• Stryker Navigation System - Hip Module (K022365)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract image of a human figure, with three faces in profile, one behind the other.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

February 23, 2017

Stryker Corporation % Calley Herzog Senior Consultant Biologics Consulting Group 400 N Washington St. Suite 100 Alexandria, Virginia 22314

Re: K162937

Trade/Device Name: Stryker Orthomap Versatile Hip System Regulation Number: 21 CFR 882.4560 Regulation Name: Stereotaxic Instrument Regulatory Class: Class II Product Code: OLO, HAW Dated: January 20, 2017 Received: January 23, 2017

Dear Calley Herzog:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in

{1}------------------------------------------------

the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely,

# Mark N. Melkerson -S

Mark N. Melkerson Director Division of Orthopedic Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

# Indications for Use

510(k) Number (if known) K162937

#### Device Name

Stryker OrthoMap Versatile Hip system

#### Indications for Use (Describe)

The Stryker OrthoMap Versatile Hip system, which is comprised of the OrthoMap Versatile Hip 2.0 Software and a platform of the NAV3i platform family, is intended as a planning and intraoperative guidance system to enable open or percutaneous image guided surgery.

The system can be used for intraoperative guidance where a reference to a rigid anatomical structure such as but not limited to the pelvis, or femur, can be identified.

The system is indicated for conditions of the hip joint in which the use of image guided surgery may be appropriate.

The Stryker OrthoMap Versatile Hip system is indicated for the following surgical procedures:

· Any form of Total Hip Athroplasty (THA), e.g. open or minimally-invasive

- · Precisely position instruments, implants and bony tissue during orthopedic hip surgery
· Revisions

| Type of Use (Select one or both, as applicable) | |
|-------------------------------------------------|--|
|-------------------------------------------------|--|

|X Prescription Use (Part 21 CFR 801 Subpart D)

| | Over-The-Counter Use (21 CFR 801 Subpart C)

#### CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

# 510(K) SUMMARY

In accordance with 21 CFR 807.87(h) and (21 CFR 807.92) the 510(k) Summary for the Stryker OrthoMap Versatile Hip system is provided below.

| Device Common Name: | Orthopedic Stereotaxic Instrument |
|----------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Device Trade Name: | Stryker OrthoMap Versatile Hip system |
| Applicant: | Stryker Leibinger GmbH & Co. KG<br>Boetzinger Strasse 41<br>D-79111 Freiburg, Germany<br>Phone number: [phone]<br>Fax number: [phone] |
| Contact: | Bjoern Lampart<br>Stryker Leibinger GmbH & Co. KG<br>Boetzinger Strasse 41<br>D-79111 Freiburg, Germany<br>P [phone]<br>C [phone]<br>F [phone]<br>[e-mail] |
| Prepared by: | Calley Herzog<br>Senior Consultant<br>Biologics Consulting Group, Inc.<br>[e-mail]<br>Phone: [phone] |
| Date Prepared: | October 19, 2016 |
| Classification Regulation: | §882.4560 - Stereotaxic Instrument |
| Panel: | Orthopedic |
| Product Code: | OLO - Orthopedic Stereotaxic Instrument |
| Predicate Device: | K022365 - Stryker Navigation System - Hip Module |

{4}------------------------------------------------

## Indication for Use:

The Stryker OrthoMap Versatile Hip system, which is comprised of the OrthoMap Versatile Hip 2.0 Software and a platform of the NAV3i platform family, is intended as a planning and intraoperative guidance system to enable open or percutaneous image guided surgery.

The system can be used for intraoperative guidance where a reference to a rigid anatomical structure such as but not limited to the pelvis, or femur, can be identified.

The system is indicated for conditions of the hip joint in which the use of image guided surgery may be appropriate.

The Stryker OrthoMap Versatile Hip system is indicated for the following surgical procedures:

- | Any form of Total Hip Athroplasty (THA), e.g. open or minimally-invasive
- Precisely position instruments, implants and bony tissue during orthopedic hip । surgery
- । Revisions

## Device Description:

The Stryker OrthoMap Versatile Hip system is intended to be used as a planning and intraoperative guidance system to enable open or percutaneous computer assisted surgery. The system uses wireless optical tracking technology to display to the surgeon the intraoperative location of navigated surgical instruments relative to a computed anatomical model of the patient's hip (pelvis and femur). The computed model is based on an intra-operative anatomy survey of the pelvis and leg as described in the following chapters. The system consists of a Stryker surgical software application (software), which runs on a platform, consisting of a Stryker computer (computer), a navigation camera, an IO-Tablet and a monitor. The Stryker surgical software application interfaces with smart instruments (e.g. patient trackers, instrument trackers or pointers) and several accessories enabling the tracking of surgical instruments.

The Stryker OrthoMap Versatile Hip software, as well as the dedicated instruments, are compatible and represent an open platform for different implant systems. The Stryker OrthoMap Versatile Hip software provides alignment and orientation of instruments, trials and ultimately implants. The system also enables intra-operative and post implantation assessments of the patient's joint stability, ROM, and leg length and leg offset.

The Stryker OrthoMap Versatile Hip software allows the user to customize workflow by selecting to navigate either the cup, the stem, or both. The user settings can be adjusted to match the surgeon's preferences. The Stryker Navigation System enables navigation of dedicated Stryker Cup and Stem Instruments as well as generic navigation of various major cup instruments.

The Stryker OrthoMap Versatile Hip 2.0 Software is compatible with the NAV3i Platform Family. The NAV3i platform family is a family of platforms that, when used with a surgical software application, displays patient specific images and/or patient specific anatomical landmark information and tracks the position and movement of surgical instruments in relation to a target anatomical site on a patient.

{5}------------------------------------------------

The following three platforms in the NAV3i platform family have been previously cleared independently or with other Stryker surgical software applications and are compatible with the Stryker OrthoMap Versatile Hip 2.0 Software:

- Stryker NAV3 Platform ●
- Stryker NAV3i Platform
- Stryker NAVSuite3 Kit

The platforms consist of the following components:

- Stryker computer (w/NAV3i OS and Surgical Software Application)
- Navigation camera
- IO-Tablet
- Monitor
- Mobile cart (if applicable)

Note that the NAV3i OS is the common software operating system for all Stryker Navigation Platforms. The Surgical Software Applications are indication specific and are designed to run on any Stryker Computer preconfigured with the NAV3i OS.

#### Performance Data:

The following performance data were provided in support of the substantial equivalence decision:

#### Electrical Safety and Electromagnetic Compatibility (EMC) Testing

Electrical safety and EMC testing were conducted on the subject device in accordance with the following standards:

- ANSI/AAMI ES60601-1:2005/(R)2012 and A1:2012, C1:2009/(R)2012 and ● A2:2010/(R)2012 (Consolidated Text) Medical electrical equipment - Part 1: General requirements for basic safety and essential performance (IEC 60601-1:2005, MOD) (FDA Rec# 19-4)
- IEC 60601-1-2:2007: Medical electrical equipment Part 1-2: General requirements . for basic safety and essential performance - Collateral standard: Electromagnetic compatibility - Requirements and tests (FDA Rec#19-1)

#### Software Verification and Validation Testing

Software verification and validation testing were conducted and documentation was provided as recommended by FDA's Guidance for Industry and FDA Staff, "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices." The software for this device was considered as a "MAJOR" level of concern.

#### Performance Testing - Bench

The following design verification activities have been performed to ensure the correct functionality of the system as it has been specified:

{6}------------------------------------------------

- . ASTM accuracy testing verifying the accuracy performance of the localization and tracking technology using the standardized test procedure according to ASTM Standard F2554-10.
- System accuracy testing verifying the specified accuracy of ± 2 mm and ± 2° using a mechanical leg mimicking the patient's anatomy.
- Clinical workflow testing verifying that all system components (application, computer platform and accessories) are compatible. Complete total hip arthroplasty procedures are simulated using Sawbones mimicking the patient's anatomy.
- Functional testing to ensure that all functional requirements are fulfilled.
- . Safety testing verifying the effectiveness of all risk controls determined in the device risk analysis and in the risk analyses of the platforms.

This strategy ensures the verification of the accuracy, system integration, software algorithms, system functionality, and correct implementation of the risk control measures. All tests have been successfully completed.

## Animal Study

No animal studies were performed to support substantial equivalence.

## Clinical Studies

No clinical studies were performed to support substantial equivalence.

## Substantial Equivalence Rationale:

The intended uses of the subject and predicate devices are similar. The systems are intended as planning and intraoperative guidance systems to enable open or percutaneous computer assisted surgery. Minor modifications were made to the indication for use statement to provide clarification, but do not change the meaning of the indication for use statement.

Both the subject device and the primary predicate device use the same main system components, use similar modes of operation, and use the same localization and tracking technology. Also, both systems use similar accessories (Smart Instruments, Patient Tracker Fixation, Navigated Manual Instruments and other accessories).

The technological characteristics of the subject and predicate device are equivalent. None of the changes alter the operating principle, the control mechanism, the localization and tracking technology, the main system components or the system accuracy performance. The workflow, user interaction, software architecture and the software features are similar. As demonstrated by the performance testing described above, the subject device continues to meet the same accuracy specifications as the predicate device. Therefore, the differences in technological characteristics to do not raise new questions of safety and effectiveness.

The device comparison table below provides a comparison of the technological characteristics of the subject device to the primary predicate device.

{7}------------------------------------------------

| | Subject Device | Predicate Device |
|-----------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| | Stryker OrthoMap Versatile Hip System | Stryker Navigation System – Hip Module |
| 510(k) Number | Under review | K022365 |
| Clearance Date | Under review | January 22, 2003 |
| Device Name | Stryker Navigation OrthoMap Versatile Hip<br>System | Stryker Navigation System - Hip Module |
| Regulation<br>Number | §882.4560 - Stereotaxic Instrument | §882.4560 - Stereotaxic Instrument |
| Product Code | OLO - Orthopedic Stereotaxic Instrument | HAW - Neurological Stereotaxic<br>Instrument |
| Product Class | II | II |
| Localization<br>and Tracking<br>technology | Infrared optical active sensing technology:<br>Infrared light emitted by diodes placed in a<br>known fashion on navigated surgical<br>instruments is sensed by a camera array<br>(navigation camera) on the computer platform,<br>thus allowing for computation of the spatial<br>information. | Infrared optical active sensing technology:<br>Infrared light emitted by diodes placed in a<br>known fashion on navigated surgical<br>instruments is sensed by a camera array<br>(navigation camera) on the computer<br>platform, thus allowing for computation of<br>the spatial information. |
| Main System<br>Components | Computer Platform<br>OrthoMap Versatile Hip 2.0 Software<br>Smart Instruments<br>Patient Tracker Fixation<br>Navigated Manual Instruments<br>Instrument Battery, Trays | Computer Platform<br>Hip Software 1.0<br>Smart Instruments<br>Patient Tracker Fixation<br>Navigated Manual Instruments<br>Instrument Battery, Trays |
| Compatible<br>Platforms | NAV3i Computer Platform Family:<br>Stryker NAV3 Platform<br>Stryker NAV3i Platform<br>Stryker NAVSuite3 Kit | Cart I, Laptop I |
| Registration<br>and Navigation<br>Work Flow | Register Pelvis<br>Register Femur<br>Model Verification<br>Acetabulum Preparation<br>Femur Preparation<br>Reduction | Register Pelvis<br>Register Femur<br>Model Verification<br>Acetabulum Preparation<br>Femur Preparation<br>Reduction |
| System<br>Accuracy | The system enables the determination of the<br>mechanical axes of the leg as well as cut and<br>component alignment with a mean<br>translational error of < $2$ mm and a mean<br>rotational error of < $2°$ . | The system enables the determination of the<br>mechanical axes of the leg as well as cut and<br>component alignment with a mean<br>translational error of < $2$ mm and a mean<br>rotational error of < $2°$ . |
| | Subject Device | Predicate Device |
| | Stryker OrthoMap Versatile Hip System | Stryker Navigation System – Hip Module |
| Accessories:<br>Patient /<br>Instrument<br>Trackers | Patient/Instrument Trackers:<br>• Hip Femur Tracker<br>• Hip Tibial/Pelvic Tracker<br>• Instrument Tracker<br>Backup Trackers:<br>• Universal Tracker<br>• Tibial/Pelvic Tracker<br>• Femoral Tracker<br>Pointers<br>• Pointer, Knee Navigation<br>• Ortho Grip Knee Pointer<br>• Hip Pointer, Straight | Patient/Instrument Trackers<br>• Hip Femur Tracker<br>• Hip Tibial/Pelvic Tracker<br>• Instrument Tracker<br>Pointers<br>• Pointer, Knee Navigation<br>• Hip Pointer, Straight |
| Accessories:<br>Patient Tracker<br>Fixation | OrthoLock with OrthoLock Navigation Pin or<br>OrthoLock EX-Pins | Anchoring Pin |
| Accessories:<br>Axis Guides | Axis Guide<br>Axis Guide, Small | Not applicable to the predicate device. |
| Screwdrivers | Screwdriver<br>Universal Joint Screwdriver | Not applicable to the predicate device. |

# Device Comparison Table:

{8}------------------------------------------------

## Substantial Equivalence Conclusion:

Based on the comparison of intended use and technological characteristics, the device is similar to the predicate device. The hardware and software verification and validation testing demonstrate that the subject device meets its performance specifications and will perform as intended in the specified use conditions and that any differences between the subject device and predicate device do not raise new questions of safety and effectiveness. Therefore, the subject device can be found substantially equivalent to the predicate device.